Failure ≥3 Lines of Therapies
1 clinical trials · Condition
◉ Watch Failure ≥3 Lines of Therapies
| Record | Firm | Date |
|---|---|---|
| A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia (NCT06770504) | Institute of Hematology & Blood Diseases Hospital, China | 2025-01-16 |
Track Failure ≥3 Lines of Therapies automatically
Every clearance here is in the API, with alerts when new ones post.